restarting semaglutide after a month Wegovy 1 Month: What to Know | GLP Trackr Stopping GLP-1s Safely: What to

C.Cuenca-EstrellaM.Alastruey-IzquierdoA

A systematic review of drug-drug interactions with GLP-1RAs found that most co-administered oral drugs did not experience clinically significant changes in total exposure (AUC), although reduced peak concentrations (Cmax) and delayed time to peak (Tmax) were commonly observed, particularly for drugs with high solubility and permeability ( Additionally, the common adverse effects of GLP-1RAs, such as nausea, constipation, and abdominal pain, frequently masquerade as an IBD flare

This means any substance that: Is not approved by any governmental regulatory health authority for human therapeutic use (e.g., drugs under pre-clinical or clinical development)

Diabetes Therapy 11(1):3752